tri semaglutide EASD 2023: meta-analysis shows tirzepatide superiority to Semaglutide and Beyond: Exploring New

Investigation of the long-term sustainability of changes in appetite after weight loss

For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety

This data-driven approach prevents both over-medication and under-medication, keeping you in a safe therapeutic window

Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex

Effective immediately, Stelara will no longer be included in our international sourcing program

Pharmacokinetics in the newborn